Fig. 2.
Multifactorial biomarkers of clinical outcome of ICB therapy. Key elements in biomarker for ICB therapy. The tumor cell itself, TME, and the immune system must be considered in the ongoing efforts in biomarker development for ICB therapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.